Effects of Low Dose Naltrexone in Fibromyalgia

Not Recruiting

Trial ID: NCT00568555

Age - 18 Years-65 Years Gender - All Accepting Healthy Volunteers - No

Purpose

Low Dose Naltrexone (LDN) has been reported anecdotally to reduce the symptoms of Fibromyalgia, a Chronic Multisystem Illness. The drug may work by regulating natural pain-reducing systems. In this study, we will administer both LDN and placebo to a small group of individuals with Fibromyalgia and Gulf War Syndrome, both Chronic Multisymptom Illnesses, to assess the drug's efficacy in treating the condition.

Official Title

Effects of Low Dose Naltrexone in Fibromyalgia

Eligibility


Inclusion Criteria:

Currently suffering from moderate to severe Fibromyalgia or symptoms of Gulf War Syndrome
Age 18-65. Not taking any opioid analgesic Not pregnant or planning to become pregnant.

Exclusion Criteria:

Any known allergy to naltrexone or naloxone. Actual or planned pregnancy.

View More
View Less

Intervention(s):

drug: Placebo - sugar pill

drug: Low Dose Naltrexone

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jarred Younger

©2024 Stanford Medicine